State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

(2017) Guy Chouinard et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report

(2017) Shigenori Tadokoro et al.   Clinical Psychopharmacology and Neuroscience

New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling

(2015) Tarsis F. Brust et al.   BIOCHEMICAL PHARMACOLOGY

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia

(2015) Masayuki Takase et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Translating the MAM model of psychosis to humans

(2015) Gemma Modinos et al.   TRENDS IN NEUROSCIENCES

Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia

(2014) Stephanie M. Perez et al.   PSYCHONEUROENDOCRINOLOGY

Prior Antipsychotic Drug Treatment Prevents Response to Novel Antipsychotic Agent in the Methylazoxymethanol Acetate Model of Schizophrenia

(2014) K. M. Gill et al.   SCHIZOPHRENIA BULLETIN

Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver

(2013) Scott A. Schobel et al.   NEURON

Peripubertal Diazepam Administration Prevents the Emergence of Dopamine System Hyperresponsivity in the MAM Developmental Disruption Model of Schizophrenia

(2013) Yijuan Du et al.   NEUROPSYCHOPHARMACOLOGY

Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons

(2012) Mark A. Ungless et al.   TRENDS IN NEUROSCIENCES

Antipsychotic Drugs Rapidly Induce Dopamine Neuron Depolarization Block in a Developmental Rat Model of Schizophrenia

(2011) O. Valenti et al.   JOURNAL OF NEUROSCIENCE

Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis

(2011) S. Tadokoro et al.   SCHIZOPHRENIA BULLETIN

Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders

(2009) Scott A. Schobel et al.   ARCHIVES OF GENERAL PSYCHIATRY

A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia

(2009) D. J. Lodge et al.   JOURNAL OF NEUROSCIENCE

A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia

(2008) Stefan Leucht et al.   AMERICAN JOURNAL OF PSYCHIATRY

Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery

(2008) Anne-Noël Samaha et al.   BIOLOGICAL PSYCHIATRY

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes

(2008) Guy Chouinard et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS